Entheon Biomedical CEO Timothy Ko On The Potential Of Psychedelics In Addiction Treatment
Among the biggest challenges faced by the psychedelics industry is the stigma that surrounds it.
"The anti-drug marketing of the past decades was highly effective, and so now when psychedelics are mentioned, visions of tie-dye come to mind," Timothy Ko told Benzinga.
The times are changing.
